Skip to main content
Premium Trial:

Request an Annual Quote

Big Pharma Tacks Hard

While big pharma have tried many things, including tapping smaller biotech firms and outsourcing R&D, trying something new like starting over is notable. Merck, Pfizer, and Eli Lilly have gotten funding to launch Enlight Biosciences, a company that will focus on previously ignored technologies and work to "smooth out the transition from animal testing to human testing that often puts a kink in the discovery process," says a Forbes article.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.